Leading the future of Mold Toxicity treatment
Our work combines the latest clinical insights and real-world outcomes to develop the most advanced treatments available today.
Dr. Ritchie Shoemaker
Dr. Scott McMahon
Dr. Margaret DiTulio
key research areas:
Identifying biomarkers for Mold Toxicity exposure
Developing next-gen precision treatments
Investigating the long-term effects of mold exposure
Our approach
We bridge the gap between science & patient care
The health impacts of mold are often misunderstood and misdiagnosed. MoldCo is changing that by pioneering research into the biological mechanisms of Mold Toxicity, while advancing awareness of the issue.
Our clinical model connects research, expert provider training, and real-world patient outcomes so patients can move from confusion to an evidence-based care path.
Hear from the minds shaping mold care
Backed by research and grounded in clinical practice, these conversations explore the science transforming patient outcomes.
“Three decades of CIRS research have helped define published diagnostic markers, treatment sequencing, and a clearer clinical language for water-damaged building illness.”
Research context from Dr. Ritchie Shoemaker's published work
Our network
A network dedicated to mold treatment science
Following Dr. Shoemaker's pioneering work, MoldCo's research efforts are led by some of the top clinicians and scientists in the field of environmental medicine.
Research pioneer
Dr. Ritchie Shoemaker
Founder of CIRS Research
Medical director
Dr. Scott McMahon
Medical Director, CMM
Clinical leader
Dr. Margaret DiTulio
Clinical Director, Regenix Healing
Research network
Peer reviewed research from our team
Research we've authored or contributed to in the field of Chronic Inflammatory Response Syndrome (CIRS).
RNA-Seq on Patients with Chronic Inflammatory Response Syndrome (CIRS)
Dr. Ritchie Shoemaker
An Evaluation of Alternate Means to Diagnose Chronic Inflammatory Response Syndrome and Determine Prevalence
Dr. Scott McMahon
Diagnostic Process for Chronic Inflammatory Response Syndrome (CIRS): A Consensus Statement Report
Dr. Ritchie Shoemaker, Dr. Scott McMahon
Advance mold treatment science with us
Talk with MoldCo about clinical research, evidence review, and provider collaboration.
95% of tracked patients report fewer symptoms in their first 30 days*
Start with a provider who understands what you're going through.
Disclaimer
*Based on 61 patients tracked by MoldCo, including non-compliant patients and those still in their environment. Measures reduction in symptom count. Individual results may vary.
The information and guidance on this website is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. You should consult your healthcare providers to rule out other potential illnesses or conditions that may be causing their symptoms. Any health-related claims made on MoldCo's website have not been evaluated by the Food and Drug Administration (FDA). MoldCo assumes no responsibility or liability for any errors or omissions in any content and content of the references nor for any actions taken in reliance thereon. MoldCo does not guarantee that the treatments or recommendations provided through this platform will lead to an improvement in symptoms. Individual results may vary, and patients are encouraged to seek further evaluation and treatment from their healthcare providers.
Clinical services are provided by a network of independent providers including, without limitation, an affiliated clinical practice, Immune Co Medical Group P.A., and its related professional entities which are independent entities. MoldCo is a healthcare technology company and not a laboratory or medical provider. We make available certain products and services sold or offered by MoldCo and/or by affiliated practices, third-party licensed clinicians, participating pharmacies, CLIA-certified laboratories (collectively, the "Providers"), or other vendors. Any services you receive from the Providers or other vendors may be subject to additional terms and conditions from those Providers or vendors. All laboratory and medical services are provided to individuals who register as members by independent third parties such as the Providers or other vendors. These Providers and other vendors set their own pricing.
Although MoldCo may facilitate easy access to certain laboratory and medical service providers on your behalf, MoldCo does not recommend or refer you to any healthcare providers, and you are free to choose any healthcare provider and continue to use MoldCo's services. MoldCo does not offer medical advice, laboratory services, a diagnosis, or any form of medical opinion, through our services or otherwise. MoldCo's pricing includes technology and service fees charged by MoldCo, as well as access to limited prepaid laboratory and other services provided by third parties, and paid to such third parties on your behalf. Itemization of all fees is available upon request. For other important information regarding the services provided by MoldCo, please see Terms of Service.
Certain products available through our website located at www.MoldCo.com together with all of its sub-domains and mobile-enabled websites (the "Platform") require a valid prescription by a licensed healthcare provider. You will not be able to obtain a prescription product unless you have completed a consultation with one of the Providers through the Platform or in person as may be required by federal or state laws, the Provider has determined the prescription product is appropriate for you and the Provider has written a prescription. If a Provider determines a prescription product is appropriate for you and writes a prescription, you may fill it through one of the Pharmacies by using the Platform. If you complete a consultation with a Provider and fill a prescription through one of the Pharmacies, the prescription product will be shipped to you by the applicable Pharmacy.